Nao Medical

Nao Medical's StuyTown location in Manhattan, New York is a REMS-certified facility offering FDA-approved Spravato (esketamine) for eligible adults with treatment-resistant depression and for certain adults with major depressive disorder and acute suicidal ideation. Esketamine works differently than traditional antidepressants, acting on the brain's glutamate system.

Care includes clinical evaluation, benefits verification, prior authorization support, monitored in-office dosing with a post-dose observation period, and transportation planning for treatment days, with a dedicated care manager for each eligible patient.

Anchoring the Manhattan side of the Spravato program, the StuyTown clinic offers in-city access to supervised care, accepting major insurance plans including Medicaid, Medicare, and commercial coverage, with benefits verified before treatment begins.